User profiles for "author:Luis Ines"

Inęs Luís

Instructor
Verified email at dfci.harvard.edu
Cited by 3032

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

JAP Da Silva, JWG Jacobs, JR Kirwan… - Annals of the …, 2006 - ard.bmj.com
Adverse effects of glucocorticoids have been abundantly reported. Published reports on low
dose glucocorticoid treatment show that few of the commonly held beliefs about their …

Contributions of the international plant science community to the fight against human infectious diseases–part 1: epidemic and pandemic diseases

M Lobato Gomez, X Huang, D Alvarez… - Plant biotechnology …, 2021 - Wiley Online Library
Infectious diseases, also known as transmissible or communicable diseases, are caused by
pathogens or parasites that spread in communities by direct contact with infected individuals …

IL-12 and IL-23/Th17 axis in systemic lupus erythematosus

M Larosa, M Zen, M Gatto, D Jesus… - Experimental …, 2019 - journals.sagepub.com
Systemic lupus erythematosus (SLE) is a very complex disease where multiple
immunological pathways can concur in inducing tissue damage. Cytokines are key …

Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics versus American College of Rheumatology criteria. A comparative …

L Inęs, C Silva, M Galindo… - Arthritis care & …, 2015 - Wiley Online Library
Objective The new Systemic Lupus International Collaborating Clinics (SLICC) 2012
classification criteria aimed to improve the performance of systemic lupus erythematosus …

Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system

CSB Viegas, MS Rafael, JL Enriquez… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—Vascular and valvular calcifications are pathological processes regulated by
resident cells, and depending on a complex interplay between calcification promoters and …

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

A Fanouriakis, M Kostopoulou, J Andersen… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the management of systemic lupus
erythematosus (SLE) based on emerging new evidence. Methods An international Task …

Derivation and validation of the SLE disease activity score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity

D Jesus, A Matos, C Henriques, M Zen… - Annals of the …, 2019 - ard.bmj.com
Objectives To derive and validate a new disease activity measure for systemic lupus
erythematosus (SLE), the SLE Disease Activity Score (SLE-DAS), with improved sensitivity …

[HTML][HTML] Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO)

A Dumas, IV Luis, T Bovagnet… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Adverse effects of breast cancer treatment can negatively affect survivors' work
ability. Previous reports lacked detailed clinical data or health-related patient-reported …

Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus

A Henriques, L Inęs, M Couto, S Pedreiro, C Santos… - Cellular …, 2010 - Elsevier
To compare frequency and functional activity of peripheral blood (PB) Th (c) 17, Th (c) 1 and
Treg cells and the amount of type 2 cytokines mRNA we recruited SLE patients in active (n …

NK cells dysfunction in systemic lupus erythematosus: relation to disease activity

A Henriques, L Teixeira, L Inęs, T Carvalheiro… - Clinical …, 2013 - Springer
Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate
autoimmune diseases. However, their role in the pathogenesis of systemic lupus …